These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8775801)

  • 1. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors as adjuncts to antiretroviral therapy.
    Miles SA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1073-80. PubMed ID: 1380256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
    Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
    Miles SA; Golde DW; Mitsuyasu RT
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):267-80. PubMed ID: 2022593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL; Berti P
    Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.
    Armstrong WS; Kazanjian P
    Clin Infect Dis; 2001 Mar; 32(5):766-73. PubMed ID: 11229845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus.
    Mitsuyasu RT
    Rev Infect Dis; 1991; 13(5):979-84. PubMed ID: 1720567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematopoietic growth factors in antineoplastic therapy from the therapeutic and economic aspect].
    Adam Z; Vorlícek J; Tomíska M
    Vnitr Lek; 1993 May; 39(5):487-500. PubMed ID: 7688919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies.
    Miles SA
    Cancer Invest; 1991; 9(2):229-38. PubMed ID: 1713806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of GM-CSF in AIDS.
    Scadden DT
    Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors in AIDS.
    Groopman JE; Feder D
    Semin Oncol; 1992 Aug; 19(4):408-14. PubMed ID: 1380730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients.
    Perrella O; Finelli E; Perrella A; Tartaglia G; Scognamiglio P; Scalera G
    J Chemother; 1996 Feb; 8(1):63-6. PubMed ID: 8835112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.